Search Results
Reduce Residual Cardiovascular Disease Risk - Nathan D. Wong, PhD, FACC, FAHA
Drs. Roger Blumenthal, JoAnne Foody, and Nathan D. Wong, Elsevier Authors, at AHA 2011
#AHA18 Scientific Sessions - Dr. Nathan Wong on the AHA's new Cholesterol Guidelines
Optimizing Lipid Risk Factors: Focus on Residual Risk, Dr. David Vorchheimer
New evidence in heart disease - Reducing residual risk
How to Better Identify Patients at Cardiovascular Residual Risk?
Giuseppe AMBROSIO: "Residual CVD risk: where are we?"
Reducing CVD Residual Risk Reduction with Icosapent Ethyl (K. Nasir, MD & guests) February 3, 2021
Management of Residual Cardiovascular Risk
Lipoprotein-a and Cardiovascular Disease: Reduction of Cardiovascular Events with Icosapent Ethyl
Better Strategies to Reduce Cardiovascular Events
AACE 22 Conference Update by Eliot A. Brinton
